市場調査レポート

商品コード

1766577

遺伝子検査市場：検査タイプ別、技術別、用途別、患者年齢層別、エンドユーザー別、地域別

Hereditary Testing Market, By Test Type, By Technology, By Application, By Patient Age Group, By End User, By Geography

出版日: 2025年06月04日
発行: Coherent Market Insights
ページ情報: 英文 165 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,500 675,225円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,050,350円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,500,500円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=150.05円

全表示
概要
目次

概要

サンプル依頼リストに入れる

遺伝子検査市場は、2025年に78億1,000万米ドルと推定され、2032年には138億4,000万米ドルに達すると予測され、2025年から2032年までの年間平均成長率（CAGR）は8.5%で成長する見込みです。

レポート範囲		レポート詳細
基準年	2024	2025年の市場規模	78億1,000万米ドル
実績データ	2020年から2024年まで	予測期間	2025年から2032年
予測期間：2025年～2032年CAGR：	8.50%	2032年の価値予測	138億4,000万米ドル

世界の遺伝子検査市場は、遺伝子技術の進歩や病気の早期発見と予防の重要性に対する意識の高まりによって、近年大きな成長を遂げています。遺伝子検査は、個人のDNAを分析して、特定の遺伝性疾患の開発リスクを高める可能性のある遺伝的変異を特定します。この市場には、がん、心血管疾患、神経疾患、希少遺伝子疾患など、幅広い遺伝子検査が含まれます。疾患の遺伝的基盤に関する理解が拡大し続けるにつれて、遺伝子検査に対する需要は増加し、市場の成長に拍車がかかると予想されます。さらに、消費者向け遺伝子検査キットの入手可能性が高まっていることや、個別化医療アプローチの採用が拡大していることも、市場の拡大にさらに寄与しています。

市場力学

世界の遺伝子検査市場は、いくつかの主要な促進要因、市場抑制要因、および機会の影響を受けています。主な促進要因の1つは、早期発見と予防の重要性に対する意識の高まりと相まって、世界中で遺伝性疾患の有病率が増加していることです。次世代シークエンシング（NGS）などの遺伝子シークエンシング技術の進歩により、遺伝子検査がより身近で手頃なものになり、市場の成長をさらに促進しています。さらに、治療計画を調整するために遺伝子情報に依存する個別化医療アプローチの採用拡大が、遺伝子検査市場に大きな機会をもたらしています。しかし、遺伝子検査費用の高さ、償還政策の制限、遺伝子のプライバシーや差別をめぐる倫理的懸念など、市場には一定の抑制要因もあります。

本調査の主な特徴

本レポートでは、世界の遺伝子検査市場を詳細に分析し、2024年を基準年とした予測期間（2025-2032年）の市場規模（10億米ドル）および複合年間成長率（CAGR%）を掲載しています。
また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。
また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の遺伝子検査市場の主要企業プロファイルを掲載しています。
このレポートからの洞察は、マーケティング担当者や企業の経営陣が、将来の製品の発売、タイプのアップグレード、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にします。
この調査レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者を対象としています。
利害関係者は、世界の遺伝子検査市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 7.81 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.50%	2032 Value Projection:	USD 13.84 Bn

The global hereditary testing market has witnessed significant growth in recent years, driven by advancements in genetic technology and increasing awareness about the importance of early disease detection and prevention. Hereditary testing involves analyzing an individual's DNA to identify genetic variations that may increase the risk of developing certain inherited disorders. This market encompasses a wide range of genetic tests, including those for cancer, cardiovascular diseases, neurological disorders, and rare genetic conditions. As the understanding of the genetic basis of diseases continues to expand, the demand for hereditary testing is expected to rise, fueling market growth. Moreover, the increasing availability of direct-to-consumer genetic testing kits and the growing adoption of personalized medicine approaches are further contributing to the market's expansion.

Market Dynamics

The global hereditary testing market is influenced by several key drivers, restraints, and opportunities. One of the primary drivers is the increasing prevalence of genetic disorders worldwide, coupled with the rising awareness about the importance of early detection and prevention. Advancements in genetic sequencing technologies, such as next-generation sequencing (NGS), have made genetic testing more accessible and affordable, further driving market growth. Moreover, the growing adoption of personalized medicine approaches, which rely on genetic information to tailor treatment plans, is creating significant opportunities for the hereditary testing market. However, the market also faces certain restraints, such as the high cost of genetic testing, limited reimbursement policies, and ethical concerns surrounding genetic privacy and discrimination.

Key features of the study

This report provides in-depth analysis of the global hereditary testing market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global hereditary testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Illumina, Inc., Thermo Fisher Scientific Inc., Myriad Genetics, Inc., Agilent Technologies, Inc., Fulgent Genetics, Inc., Genomic Health, Inc., Invitae Corporation, Roche Diagnostics, Siemens Healthineers, BGI Genomics, Quest Diagnostics, PerkinElmer, Inc., Eurofins Scientific, ArcherDX, and Color Genomics.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global hereditary testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hereditary testing market

Market Segmentation

Test Type Insights (Revenue, USD Bn, 2020 - 2032)
- Predictive Testing
- Diagnostic Testing
- Carrier Testing
- Prenatal Testing
- Newborn Screening
- Preimplantation Genetic Diagnosis (PGD)
- Pharmacogenomic Testing
Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Microarray
- Fluorescence In Situ Hybridization (FISH)
- Sanger Sequencing
- Array Comparative Genomic Hybridization (aCGH)
Application Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology
- Cardiovascular Diseases
- Neurology
- Metabolic Disorders
- Rare Diseases
- Reproductive Health
- Others
Patient Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Pediatric
- Adult
- Geriatric
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Specialty Clinics
- Diagnostic Laboratories
- Research Institutions
- Home Care Settings
- Others
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Myriad Genetics, Inc.
- Agilent Technologies, Inc.
- Fulgent Genetics, Inc.
- Genomic Health, Inc.
- Invitae Corporation
- Roche Diagnostics
- Siemens Healthineers
- BGI Genomics
- Quest Diagnostics
- PerkinElmer, Inc.
- Eurofins Scientific
- ArcherDX
- Color Genomics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Hereditary Testing Market, By Test Type
- Global Hereditary Testing Market, By Technology
- Global Hereditary Testing Market, By Application
- Global Hereditary Testing Market, By Patient Age Group
- Global Hereditary Testing Market, By End User
- Global Hereditary Testing Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Hereditary Testing Market, By Test Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Predictive Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Diagnostic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Carrier Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Prenatal Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Newborn Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Preimplantation Genetic Diagnosis (PGD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pharmacogenomic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Hereditary Testing Market, By Technology, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Next-Generation Sequencing (NGS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Polymerase Chain Reaction (PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Microarray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Fluorescence In Situ Hybridization (FISH)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Sanger Sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Array Comparative Genomic Hybridization (aCGH)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Hereditary Testing Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Metabolic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Rare Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Reproductive Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Hereditary Testing Market, By Patient Age Group, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Hereditary Testing Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Hereditary Testing Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Test Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Test Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Test Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Test Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Test Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Test Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Illumina, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Myriad Genetics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fulgent Genetics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Genomic Health, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Invitae Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BGI Genomics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Quest Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
PerkinElmer, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Eurofins Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
ArcherDX
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Color Genomics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

11. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us

遺伝子検査市場：検査タイプ別、技術別、用途別、患者年齢層別、エンドユーザー別、地域別

Hereditary Testing Market, By Test Type, By Technology, By Application, By Patient Age Group, By End User, By Geography

市場力学

目次

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界の遺伝子検査市場、検査タイプ別、2020年～2032年

第5章世界の遺伝子検査市場、技術別、2020年～2032年

第6章世界の遺伝子検査市場、用途別、2020年～2032年

第7章世界の遺伝子検査市場、患者年齢層別、2020年～2032年

第8章世界の遺伝子検査市場、エンドユーザー別、2020年～2032年

第9章世界の遺伝子検査市場、地域別、2020年～2032年

第10章競合情勢

第11章アナリストの推奨事項

第12章参考文献と調査手法

Market Dynamics

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Hereditary Testing Market, By Test Type, 2020-2032, (USD Bn)

5. Global Hereditary Testing Market, By Technology, 2020-2032, (USD Bn)

6. Global Hereditary Testing Market, By Application, 2020-2032, (USD Bn)

7. Global Hereditary Testing Market, By Patient Age Group, 2020-2032, (USD Bn)

8. Global Hereditary Testing Market, By End User, 2020-2032, (USD Bn)

9. Global Hereditary Testing Market, By Region, 2020 - 2032, Value (USD Bn)

10. Competitive Landscape

11. Analyst Recommendations

12. References and Research Methodology

遺伝子検査市場：検査タイプ別、技術別、用途別、患者年齢層別、エンドユーザー別、地域別

Hereditary Testing Market, By Test Type, By Technology, By Application, By Patient Age Group, By End User, By Geography

市場力学

目次

第1章 調査の目的と前提条件

第2章 市場の展望

第3章 市場力学、規制、動向分析

第4章 世界の遺伝子検査市場、検査タイプ別、2020年～2032年

第5章 世界の遺伝子検査市場、技術別、2020年～2032年

第6章 世界の遺伝子検査市場、用途別、2020年～2032年

第7章 世界の遺伝子検査市場、患者年齢層別、2020年～2032年

第8章 世界の遺伝子検査市場、エンドユーザー別、2020年～2032年

第9章 世界の遺伝子検査市場、地域別、2020年～2032年

第10章 競合情勢

第11章 アナリストの推奨事項

第12章 参考文献と調査手法

Market Dynamics

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Hereditary Testing Market, By Test Type, 2020-2032, (USD Bn)

5. Global Hereditary Testing Market, By Technology, 2020-2032, (USD Bn)

6. Global Hereditary Testing Market, By Application, 2020-2032, (USD Bn)

7. Global Hereditary Testing Market, By Patient Age Group, 2020-2032, (USD Bn)

8. Global Hereditary Testing Market, By End User, 2020-2032, (USD Bn)

9. Global Hereditary Testing Market, By Region, 2020 - 2032, Value (USD Bn)

10. Competitive Landscape

11. Analyst Recommendations

12. References and Research Methodology

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界の遺伝子検査市場、検査タイプ別、2020年～2032年

第5章世界の遺伝子検査市場、技術別、2020年～2032年

第6章世界の遺伝子検査市場、用途別、2020年～2032年

第7章世界の遺伝子検査市場、患者年齢層別、2020年～2032年

第8章世界の遺伝子検査市場、エンドユーザー別、2020年～2032年

第9章世界の遺伝子検査市場、地域別、2020年～2032年

第10章競合情勢

第11章アナリストの推奨事項

第12章参考文献と調査手法